116 related articles for article (PubMed ID: 11549061)
1. Grafting of encapsulated genetically modified cells secreting GDNF into the striatum of parkinsonian model rats.
Date I; Shingo T; Yoshida H; Fujiwara K; Kobayashi K; Takeuchi A; Ohmoto T
Cell Transplant; 2001; 10(4-5):397-401. PubMed ID: 11549061
[TBL] [Abstract][Full Text] [Related]
2. Neuroprotective and restorative effects of intrastriatal grafting of encapsulated GDNF-producing cells in a rat model of Parkinson's disease.
Shingo T; Date I; Yoshida H; Ohmoto T
J Neurosci Res; 2002 Sep; 69(6):946-54. PubMed ID: 12205688
[TBL] [Abstract][Full Text] [Related]
3. Implants of polymer-encapsulated genetically modified cells releasing glial cell line-derived neurotrophic factor improve survival, growth, and function of fetal dopaminergic grafts.
Sautter J; Tseng JL; Braguglia D; Aebischer P; Spenger C; Seiler RW; Widmer HR; Zurn AD
Exp Neurol; 1998 Jan; 149(1):230-6. PubMed ID: 9454632
[TBL] [Abstract][Full Text] [Related]
4. Continuous exposure to glial cell line-derived neurotrophic factor to mature dopaminergic transplants impairs the graft's ability to improve spontaneous motor behavior in parkinsonian rats.
Winkler C; Georgievska B; Carlsson T; Lacar B; Kirik D
Neuroscience; 2006 Aug; 141(1):521-31. PubMed ID: 16697115
[TBL] [Abstract][Full Text] [Related]
5. Dissociation between short-term increased graft survival and long-term functional improvements in Parkinsonian rats overexpressing glial cell line-derived neurotrophic factor.
Georgievska B; Carlsson T; Lacar B; Winkler C; Kirik D
Eur J Neurosci; 2004 Dec; 20(11):3121-30. PubMed ID: 15579166
[TBL] [Abstract][Full Text] [Related]
6. Human neural progenitors deliver glial cell line-derived neurotrophic factor to parkinsonian rodents and aged primates.
Behrstock S; Ebert A; McHugh J; Vosberg S; Moore J; Schneider B; Capowski E; Hei D; Kordower J; Aebischer P; Svendsen CN
Gene Ther; 2006 Mar; 13(5):379-88. PubMed ID: 16355116
[TBL] [Abstract][Full Text] [Related]
7. Transient striatal delivery of GDNF via encapsulated cells leads to sustained behavioral improvement in a bilateral model of Parkinson disease.
Sajadi A; Bensadoun JC; Schneider BL; Lo Bianco C; Aebischer P
Neurobiol Dis; 2006 Apr; 22(1):119-29. PubMed ID: 16300956
[TBL] [Abstract][Full Text] [Related]
8. Astrocyte delivery of glial cell line-derived neurotrophic factor in a mouse model of Parkinson's disease.
Cunningham LA; Su C
Exp Neurol; 2002 Apr; 174(2):230-42. PubMed ID: 11922664
[TBL] [Abstract][Full Text] [Related]
9. Increased fiber outgrowth from xeno-transplanted human embryonic dopaminergic neurons with co-implants of polymer-encapsulated genetically modified cells releasing glial cell line-derived neurotrophic factor.
Ahn YH; Bensadoun JC; Aebischer P; Zurn AD; Seiger A; Björklund A; Lindvall O; Wahlberg L; Brundin P; Kaminski Schierle GS
Brain Res Bull; 2005 Jul; 66(2):135-42. PubMed ID: 15982530
[TBL] [Abstract][Full Text] [Related]
10. Neurospheres modified to produce glial cell line-derived neurotrophic factor increase the survival of transplanted dopamine neurons.
Ostenfeld T; Tai YT; Martin P; Déglon N; Aebischer P; Svendsen CN
J Neurosci Res; 2002 Sep; 69(6):955-65. PubMed ID: 12205689
[TBL] [Abstract][Full Text] [Related]
11. Ex vivo gene delivery of GDNF using primary astrocytes transduced with a lentiviral vector provides neuroprotection in a rat model of Parkinson's disease.
Ericson C; Georgievska B; Lundberg C
Eur J Neurosci; 2005 Dec; 22(11):2755-64. PubMed ID: 16324109
[TBL] [Abstract][Full Text] [Related]
12. Delayed gene therapy of glial cell line-derived neurotrophic factor is efficacious in a rat model of Parkinson's disease.
Zheng JS; Tang LL; Zheng SS; Zhan RY; Zhou YQ; Goudreau J; Kaufman D; Chen AF
Brain Res Mol Brain Res; 2005 Mar; 134(1):155-61. PubMed ID: 15790539
[TBL] [Abstract][Full Text] [Related]
13. Delayed delivery of AAV-GDNF prevents nigral neurodegeneration and promotes functional recovery in a rat model of Parkinson's disease.
Wang L; Muramatsu S; Lu Y; Ikeguchi K; Fujimoto K; Okada T; Mizukami H; Hanazono Y; Kume A; Urano F; Ichinose H; Nagatsu T; Nakano I; Ozawa K
Gene Ther; 2002 Mar; 9(6):381-9. PubMed ID: 11960314
[TBL] [Abstract][Full Text] [Related]
14. Early transplantation of an encapsulated glial cell line-derived neurotrophic factor-producing cell demonstrating strong neuroprotective effects in a rat model of Parkinson disease.
Yasuhara T; Shingo T; Muraoka K; Kobayashi K; Takeuchi A; Yano A; Wenji Y; Kameda M; Matsui T; Miyoshi Y; Date I
J Neurosurg; 2005 Jan; 102(1):80-9. PubMed ID: 15658100
[TBL] [Abstract][Full Text] [Related]
15. Involvement of GDNF in neuronal protection against 6-OHDA-induced parkinsonism following intracerebral transplantation of fetal kidney tissues in adult rats.
Borlongan CV; Zhou FC; Hayashi T; Su TP; Hoffer BJ; Wang Y
Neurobiol Dis; 2001 Aug; 8(4):636-46. PubMed ID: 11493028
[TBL] [Abstract][Full Text] [Related]
16. Erythropoietin and GDNF enhance ventral mesencephalic fiber outgrowth and capillary proliferation following neural transplantation in a rodent model of Parkinson's disease.
McLeod M; Hong M; Mukhida K; Sadi D; Ulalia R; Mendez I
Eur J Neurosci; 2006 Jul; 24(2):361-70. PubMed ID: 16903847
[TBL] [Abstract][Full Text] [Related]
17. Neurorescue effects of VEGF on a rat model of Parkinson's disease.
Yasuhara T; Shingo T; Muraoka K; Kameda M; Agari T; Wen Ji Y; Hayase H; Hamada H; Borlongan CV; Date I
Brain Res; 2005 Aug; 1053(1-2):10-8. PubMed ID: 16045899
[TBL] [Abstract][Full Text] [Related]
18. Protection of dopaminergic nigrostriatal afferents by GDNF delivered by microspheres in a rodent model of Parkinson's disease.
Gouhier C; Chalon S; Aubert-Pouessel A; Venier-Julienne MC; Jollivet C; Benoit JP; Guilloteau D
Synapse; 2002 Jun; 44(3):124-31. PubMed ID: 11954043
[TBL] [Abstract][Full Text] [Related]
19. Long-term glial cell line-derived neurotrophic factor overexpression in the intact nigrostriatal system in rats leads to a decrease of dopamine and increase of tetrahydrobiopterin production.
Sajadi A; Bauer M; Thöny B; Aebischer P
J Neurochem; 2005 Jun; 93(6):1482-6. PubMed ID: 15935064
[TBL] [Abstract][Full Text] [Related]
20. Marked dopaminergic cell loss subsequent to developmental, intranigral expression of glial cell line-derived neurotrophic factor.
Chun HS; Yoo MS; DeGiorgio LA; Volpe BT; Peng D; Baker H; Peng C; Son JH
Exp Neurol; 2002 Feb; 173(2):235-44. PubMed ID: 11822887
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
